BiliAAP vs UmbiCalc Usage & Stats

¤ Calculator and Clinical Decision Support Systems based on AAP 2022 and NICE 2016 guidelines for the management of hyperbilirubinemia in newborns. Features: ¤ Risk curve by gestational age at birth. ¤ Algorithms for clinical decision making (AAP 2022). ¤ Calculations in mg/dl and µmol/L ¤ Extended graphs from 0 to 336 hours (0-14 Days) ¤ Original and easier-to-interpret graphs ¤ Neurotoxicity risk factors absent, present. ¤ Plot up to 2 time points to assess trends. ¤ Rate of increase between the last two measurements, if this is in danger range. ¤ Age in hours from birth dates to measurements. This application was designed and programmed by Gerson Rodriguez Quintero, Pediatrician from Universidad Del Norte, Colombia. Please contact me if you notice any discrepancies.

Apple App Store
Paid
Medical

Store Rank

- -

UmbiCalc

This app provides the birth weight-based insertion length estimations for umbilical arterial and venous catheters placed in neonates in the Neonatal Intensive Care Unit. UmbiCalc is based on the algorithm described by Tambasco et al. in “A Novel and Accurate Method for Estimating Umbilical Arterial and Venous Catheter Insertion Length.” Journal of Perinatology 2021. The algorithm was derived from statistical modeling using a representative sample of the current NICU population and validated across a wide range of birth weights. Intended for use by neonatologists, pediatricians, and advanced practice providers for personal educational purposes only. It is not intended for use in clinical practice or the delivery of medical care. Always consult with a healthcare provider for advice concerning your health.